drug

selexipag

1 story · latest Nov 10, 2026

Follow selexipag. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Dec 2015 · NDA207947, NDA214275
Brands: Uptravi, Uptravi Titration Pack
Codes: ACT-293987, JNJ-67896049
Trials: 3 registered trials in coverage

Relationships

Developed by Johnson & Johnson

Timeline

Insmed Q3 revenue tops $524 million; Brinsupri, Arikayce guidance raised, Japan launch underway

Nov 10M&Aamikacin brensocatibUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.